does semaglutide cause blood in urine and UTI: GLP-1 therapy increase urinary tract infection risk? Ozempic and Constipation: Causes, Relief,

Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and impaired insulin secretion, leading to persistent

Sold strictly for laboratory and research use only

As the buzz around GLP-1 medications grew to a fever pitch over the past two years, many digital health and telehealth companies quickly added programs to prescribe anti-obesity drugs

Overview on biological glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) effects at the organ/tissue level.

The FDA shortlist monitors drug shortages, including GLP-1 agonists

The weight loss drug semaglutide will be made available for prescription from 4 September 2023, in what its manufacturer, Novo Nordisk, has described as a controlled and limited launch of the drug